The Office of Disease Prevention (ODP)—established at NIH in 1986—works to increase the scope, quality, dissemination, and impact of prevention research by means of a comprehensive approach outlined in the 2014–2018 Strategic Plan.
Located within the ODP, the Tobacco Regulatory Science Program (TRSP) is a trans-NIH collaboration with the U.S. Food and Drug Administration (FDA). TRSP facilitates NIH research to provide the scientific evidence the FDA needs for the development and evaluation of its tobacco regulatory activities. TRSP issues funding opportunities in tobacco regulatory science on behalf of the FDA and participating NIH Institutes.
On May 5, 2016, the FDA issued its final deeming rule to extend its authorities to all categories of products that meet the statutory definition of "tobacco product" in the Federal Food, Drug, and Cosmetic Act, except accessories of such newly deemed tobacco products. In addition to products already regulated by the FDA (i.e., cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco), newly deemed products subject to regulation include cigars, pipe tobacco, hookah (waterpipe) tobacco, Electronic Nicotine Delivery Systems or ENDS (e.g., e-cigarettes, vape pens), gels, and certain dissolvable tobacco products. This final "deeming" rule also prohibits the sale of "covered tobacco products" to individuals under the age of 18 and requires the display of health warnings on cigarette tobacco, roll-your-own tobacco, and covered tobacco product packages and in advertisements. The FDA is taking this action to reduce death and disease from tobacco products, and the NIH TRSP will continue to support the research base needed to meet this goal.
The ODP has made progress toward achieving its strategic plan's goals by charting research directions at the NIH. One example is the development of new portfolio analysis tools. At the heart of this effort is a new taxonomy—or way of categorizing prevention research—and an accompanying protocol to enable an accurate, standardized classification of grant abstracts. This taxonomy is being manually applied to thousands of research grant abstracts and validated by custom software called the Prevention Abstract Classification Tool (PACT).
The ODP recently launched the Resources for Researchers web portal to connect investigators with helpful tools at the NIH. Researchers who access these pages will find information about Finding NIH-Funded Research, Applying for NIH Funding, Methods-Related Funding Opportunity Announcements, Prevention-Related Programs, Offices, and Divisions, Prevention-Related Study Sections, Prevention Research Articles and Prevention Research Needs and Gaps.
The Medicine: Mind the Gap seminar series explores issues at the intersection of research, evidence, and clinical practice—areas in which conventional wisdom may be contradicted by recent evidence. Karina W. Davidson, Ph.D., M.A.Sc., presented her talk, “N-of-1 and Novel Within-Subject Trial Methods” on May 16, 2016. A videocast of this seminar is now available. Additionally, the seminar on “Big Data and the Promise and Pitfalls When Applied to Disease Prevention and Promoting Better Health,” presented by Philip E. Bourne, Ph.D., has been rescheduled to June 13, 2016.
The Pathways to Prevention (P2P) workshops identify research gaps and develop recommendations to move fields of research forward. The recent P2P workshop, Advancing Research To Prevent Youth Suicide took place on March 29–30, 2016. Learn more.
Research Highlights provide information about funded research, current funding opportunities, and recent advances in the science of prevention. Learn more about how the NIH and its federal partners are addressing Environmental Health, Immunization and Infectious Diseases, Injury and Violence, Nutrition, Obesity, Physical Activity, Substance Abuse, and Tobacco Use.
Associate Director for Prevention
Director, Office of Disease Prevention